$1.86 Billion is the total value of Alphabet Inc.'s 56 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 8.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PATH | UiPath Inccl a | $233,117,929 | -5.6% | 14,068,674 | 0.0% | 12.53% | -8.6% | |
| VERV | Verve Therapeutics Inc. | $197,795,362 | +30.0% | 10,549,086 | 0.0% | 10.63% | +26.0% | |
| OSCR | Oscar Health Inc.cl a | $193,785,485 | +23.2% | 24,042,864 | 0.0% | 10.41% | +19.4% | |
| CRWD | Buy | Crowdstrike Hldgs Inccl a | $188,534,522 | +18.1% | 1,283,683 | +10.3% | 10.13% | +14.4% |
| Sell | Prime Medicine, Inc. | $173,785,595 | +6.4% | 11,862,498 | -10.7% | 9.34% | +3.1% | |
| DXCM | Sell | Dexcom Inc | $155,857,699 | +7.3% | 1,212,806 | -3.0% | 8.38% | +4.0% |
| Buy | Gitlab Inc. | $135,304,116 | +104.1% | 2,647,312 | +36.9% | 7.27% | +97.7% | |
| Planet Labs Inc. | $102,855,304 | -18.1% | 31,942,641 | 0.0% | 5.53% | -20.6% | ||
| SNOW | Snowflake Inccl a | $94,255,592 | +14.1% | 535,604 | 0.0% | 5.06% | +10.5% | |
| EQRX Inc | $88,676,385 | -4.1% | 47,675,476 | 0.0% | 4.76% | -7.1% | ||
| Freshworks Inc | $70,945,760 | +14.5% | 4,035,595 | 0.0% | 3.81% | +10.9% | ||
| LYFT | Lyft Inc | $35,502,698 | +3.5% | 3,702,054 | 0.0% | 1.91% | +0.3% | |
| Benson Hill Inc. | $19,957,952 | +13.0% | 15,352,271 | 0.0% | 1.07% | +9.5% | ||
| RLAY | Relay Therapeutics Inc. | $19,703,537 | -23.7% | 1,568,753 | 0.0% | 1.06% | -26.1% | |
| DM | Desktop Metal Inc. | $19,556,252 | -23.0% | 11,048,730 | 0.0% | 1.05% | -25.4% | |
| LYEL | Lyell Immunopharma Inc. | $18,651,097 | +34.7% | 5,865,125 | 0.0% | 1.00% | +30.5% | |
| SANA | Sana Biotechnology Inc. | $16,762,500 | +82.3% | 2,812,500 | 0.0% | 0.90% | +76.7% | |
| BEAM | Beam Therapeutics Inc. | $10,268,815 | +4.3% | 321,604 | 0.0% | 0.55% | +1.1% | |
| RAPT | RAPT Therapeutics Inc. | $10,103,049 | +1.9% | 540,270 | 0.0% | 0.54% | -1.3% | |
| GLUE | Monte Rosa Therapeutics Inc. | $10,028,502 | -12.1% | 1,464,015 | 0.0% | 0.54% | -14.7% | |
| ILMN | Illumina Inc. | $10,025,090 | -19.4% | 53,470 | 0.0% | 0.54% | -21.8% | |
| DBTX | Decibel Therapeutics Inc. | $6,299,593 | +27.5% | 1,636,258 | 0.0% | 0.34% | +23.4% | |
| Sell | Robinhood Mkts Inc | $6,109,896 | -87.2% | 612,214 | -87.6% | 0.33% | -87.6% | |
| Invivyd Inc. | $5,964,824 | -12.5% | 5,680,785 | 0.0% | 0.32% | -15.1% | ||
| Tenaya Therapeutics Inc. | $5,375,188 | +106.0% | 915,705 | 0.0% | 0.29% | +99.3% | ||
| VERA | Vera Therapeutics Inc.cl a | $4,840,359 | +106.8% | 301,580 | 0.0% | 0.26% | +100.0% | |
| FHTX | Foghorn Therapeutics Inc. | $3,526,343 | +13.5% | 500,901 | 0.0% | 0.19% | +9.9% | |
| VACC | Vaccitech PLCads | $3,118,106 | -8.0% | 1,513,644 | 0.0% | 0.17% | -10.6% | |
| Tscan Therapeutics Inc. | $2,692,700 | +19.0% | 1,077,080 | 0.0% | 0.14% | +16.0% | ||
| MGTA | Magenta Therapeutics Inc. | $2,537,744 | -3.8% | 3,339,138 | 0.0% | 0.14% | -6.8% | |
| KRON | Kronos Bio Inc. | $2,473,759 | +17.8% | 1,438,232 | 0.0% | 0.13% | +14.7% | |
| EXAS | Exact Sciences Corp | $2,178,950 | +38.5% | 23,205 | 0.0% | 0.12% | +34.5% | |
| Hyperfine Inc. | $1,932,248 | +49.3% | 898,720 | 0.0% | 0.10% | +44.4% | ||
| Rani Therapeutics Hldgs Inc. | $1,847,787 | -20.2% | 448,492 | 0.0% | 0.10% | -22.7% | ||
| AUTL | Autolus Therapeutics PLCspon adr | $1,661,863 | +29.3% | 698,262 | 0.0% | 0.09% | +25.4% | |
| SPRO | Spero Therapeutics Inc. | $1,290,469 | -0.0% | 889,979 | 0.0% | 0.07% | -4.2% | |
| ALEC | Alector Inc. | $1,056,954 | -2.9% | 175,866 | 0.0% | 0.06% | -5.0% | |
| Science 37 Holdings Inc. | $673,524 | -25.0% | 3,207,260 | 0.0% | 0.04% | -28.0% | ||
| OPRT | Oportun Finl Corp | $565,884 | +54.7% | 94,788 | 0.0% | 0.03% | +50.0% | |
| TSHA | Taysha Gene Therapies Inc. | $422,982 | -17.5% | 640,882 | 0.0% | 0.02% | -17.9% | |
| CRTX | Quince Therapeutics Inc | $285,574 | -3.2% | 189,122 | 0.0% | 0.02% | -6.2% | |
| NVTA | Invitae Corp | $266,235 | -16.3% | 235,606 | 0.0% | 0.01% | -22.2% | |
| New | Evelo Biosciences Inc. | $172,328 | – | 53,024 | +100.0% | 0.01% | – | |
| Mondee Holdings Inc. | $164,122 | -20.2% | 18,420 | 0.0% | 0.01% | -18.2% | ||
| FULC | Fulcrum Therapeutics Inc | $47,065 | +15.8% | 14,262 | 0.0% | 0.00% | +50.0% | |
| RGEN | Repligen Corp | $54,179 | -16.0% | 383 | 0.0% | 0.00% | -25.0% | |
| Cue Health Inc | $9,990 | -79.7% | 27,000 | 0.0% | 0.00% | -66.7% | ||
| EVLO | Exit | Evelo Biosciences Inc. | $0 | – | -1,060,495 | -100.0% | -0.01% | – |
| ME | Exit | 23andMe Holding Co. | $0 | – | -6,736,785 | -100.0% | -0.85% | – |
| Exit | Duolingo Inc. | $0 | – | -523,824 | -100.0% | -4.14% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-04
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
| AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
| Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
| DEXCOM INC | 20 | Q3 2023 | 17.4% |
| Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
| ALECTOR INC | 19 | Q3 2023 | 1.1% |
| Lyft Inc | 18 | Q2 2023 | 51.9% |
| QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
| Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
| FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| PX14A6G | 2024-05-02 |
| 144 | 2024-05-01 |
| 144 | 2024-05-01 |
| 4 | 2024-05-01 |
| PX14A6G | 2024-05-01 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.